Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR

Clinical trial NCT07129421 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07129421
Sponsor: Emblok, Inc.
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

AORTIC VALVE DISEASES Aortic Valve Stenosis and/or Insufficiency Aortic Valve Regurgitation Aortic Valve Replacement

Start date: 2025-10-21
Primary completion: 2027-01-31
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.